As of 3:59pm ET
| +0.06 / +7.41%|
TearLab Corp. engages in the development and marketing of lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing disease markers in tears at the point-of-care. Its products include TearLab Osmolarity System consisting TearLab disposable, which is a single-use microfluidic microchip; the TearLab Pen, which is a hand-held device that interfaces with the TearLab disposable; and the TearLab Reader, which is a small desktop unit that allows for the docking of the TearLab Pen and provides a quantitative reading for the operator. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in San Diego, CA.
|Joseph Jensen||President, CEO, COO & Director|
|Wes Brazell||Chief Financial Officer|
|Benjamin D. Sullivan||Chief Scientific Officer|
|Michael A. Lemp||Chief Medical Officer|
|David Craig Eldridge||VP-Clinical Affairs & Professional Development|